新兴国家_药品市场_2010(中国_巴西)PPT课件2.ppt

* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * IPO Enthusiasm Industry watchers highlight the need for caution around Chinese IPO’s Chinese pharmaceutical companies have been rushing to IPO in the U.S. before the enthusiasm disappears Mergers and Acquisitions The highly fragmented pharmaceutical industry seems like a natural candidate for MA Consolidation is underway as hotshots with IPO cash have started scooping up smaller rivals Only five months after its April 2007 NYSE listing, Simcere took a $15 million, 51 percent stake in fellow drug maker Boda. In late November, Simc